Tags Result

El-Nile for Pharmaceuticals turns profitable in Q1 FY2025/26

El-Nile Co. for Pharmaceuticals and Chemical Industries (NIPH) turned profitable, with EGP 106.525 million in the first quarter (Q1) of fiscal year (FY) 2025/2026.

Updated 10/28/2025 10:30:00 AM
El-Nile for Pharmaceuticals to distribute EGP 2/share dividend for FY2024/25

El-Nile Co. for Pharmaceuticals and Chemical Industries(NIPH) declared a cash dividend of EGP 2 per share for the fiscal year (FY) 2024/2025

Updated 10/15/2025 10:02:00 AM
El-Nile for Pharmaceuticals posts 39.35% YoY profit jump in FY2024/25

El-Nile Co. for Pharmaceuticals and Chemical Industries’ (NIPH) net profits after tax increased 39.35% year on year (YoY) in fiscal year (FY) 2024/2025, according to the company’s financial indicators.

Updated 9/9/2025 9:51:00 AM
El-Nile for Pharmaceuticals’ profits rise 1.9% YoY in 9 months

El-Nile Company for Pharmaceuticals and Chemical Industries (NIPH) logged net profits after tax worth EGP 124.659 million in the first nine months of fiscal year (FY) 2024/25

Updated 4/27/2025 12:01:00 PM
El-Nile for Pharmaceuticals to pay FY2023/24 dividends in November

El-Nile Co. for Pharmaceuticals and Chemical Industries will distribute EGP 3.71 per share in cash dividends to shareholders for fiscal year (FY) 2023/2024 on November 21st.

Updated 11/5/2024 2:59:00 AM
El-Nile for Pharmaceuticals’ profits fall 24.3% YoY in FY2023/24

El-Nile Co. for Pharmaceuticals and Chemical Industries’ (NIPH) net profits after tax dropped 24.3% year on year (YoY) in fiscal year (FY) 2023/2024.

Updated 9/22/2024 1:14:00 AM
El-Nile for Pharmaceuticals posts 15.7% YoY profit drop in FY2023/24

El-Nile Co. for Pharmaceuticals and Chemical Industries’ (NIPH) net profits after tax dropped 15.7% year on year (YoY) in fiscal year (FY) 2023/2024.

Updated 8/13/2024 10:22:00 AM
El-Nile for Pharmaceuticals’ EGM nods to capital increase

El-Nile Co. for Pharmaceuticals and Chemical Industries’ extraordinary general meeting (OGM) has approved raising the issued capital by EGP 198.75 million distributed over 198.75 million shares at a par value of EGP 10 per share.

Updated 7/1/2024 2:28:00 AM
FRA OKs capital increase for Nile Pharma

The Financial Regulatory Authority (FRA) has approved publishing the disclosure form proposed by the El Nile Company for Pharmaceuticals and Chemical Industries’ (Nile Pharma) board to raise issued and paid-up capital.

Updated 5/29/2024 2:08:00 AM
El-Nile for Pharmaceuticals’ profits surge 107% YoY in H1 FY2023/24

El-Nile Co. for Pharmaceuticals and Chemical Industries’ (NIPH) net profits after tax soared by 106.9% year on year (YoY) the first half (H1) of fiscal year (FY) 2023/2024.

Updated 1/29/2024 12:04:00 PM
Nile Pharma to pay EGP 5/share dividends in November

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Updated 11/2/2023 10:24:00 AM
Nile Pharma records 158.4% YoY higher profits in Q1 FY2023/24

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Updated 10/26/2023 9:56:00 AM
El-Nile for Pharmaceuticals posts 33% YoY profit surge in FY2022/23

El-Nile Co. for Pharmaceuticals and Chemical Industries’ (NIPH) net profits after tax increased 32.9% year on year (YoY) in fiscal year (FY) 2022/2023.

Updated 9/14/2023 10:17:00 AM
Nile Pharma’s profits jump 32.7% YoY in FY 2022/23

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Updated 8/15/2023 1:29:00 AM
Nile Pharma reports 7.3% YoY profit hike in 10 months

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Updated 5/21/2023 3:11:00 AM